• Skip to primary navigation
  • Skip to main content
  • Skip to footer
Edgewise

Edgewise Therapeutics

A Movement in Muscle

  • Clinical Trials
  • Careers
  • Investors & News
  • Menu
    • Disease Areas
    • Muscular Dystrophy
    • Hypertrophic Cardiomyopathy

    Learn more about how our science is driving a new understanding of muscle and its potential to transform human health.

    Explore Muscle

    • Science & Pipeline
    • Pipeline
    • Sevasemten
    • EDG-7500
    • Clinical Trials
    • Posters & Presentations

    All of us at Edgewise are committed to developing new medicines for people facing serious muscle diseases with unmet medical needs.

    Explore our Science

    • Patients & Families
    • Support for Becker
    • Support for Duchenne
    • Support for HCM
    • Patient Stories

    We honor the experience of individuals and families living with and facing the challenges of serious muscle disease.

    Read their Stories

    • Company
    • Leadership Team
    • Careers
    • Contact Us

    Our vision is to improve the lives of patients and families suffering from serious muscle diseases by building the world’s leading muscle-focused company.

    Learn More

    • Corporate Profile
    • News
    • Events & Presentations
    • Analyst Coverage
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Investment Calculator
    • Financials
      • Quarterly Results
      • SEC Filings
    • Governance
      • Governance Documents
      • Committee Composition
    • Resources
      • Investor FAQs
      • Investor Email Alerts
      • Investor Contacts
HomeCompanyLeadership Team

Leadership Team & Board of Directors

Experienced Life-science leadership

Focused on a new era of muscle-targeted therapeutics.

  • Leadership team
  • Board of directors

Leadership Team

Kevin Koch, Ph.D.

President and Chief Executive Officer

Read Kevin Koch, Ph.D.'s Bio

Alan Russell, Ph.D.

Co-Founder and Chief Scientific Officer

Read Alan Russell, Ph.D.'s Bio

Robert Blaustein, M.D., Ph.D.

Chief Development Officer

Read Robert Blaustein, M.D., Ph.D.'s Bio

R. Michael Carruthers

Chief Financial Officer

Read R. Michael Carruthers's Bio

Behrad Derakhshan, Ph.D.

Chief Operating Officer

Read Behrad Derakhshan, Ph.D.'s Bio

Joanne M. Donovan, M.D., Ph.D.

Chief Medical Officer

Read Joanne M. Donovan, M.D., Ph.D.'s Bio

John Moore

General Counsel

Read John Moore's Bio

Board of Directors

Peter Thompson, M.D.

Chairman and Co-Founder

Read Peter Thompson, M.D.'s Bio

Laura Brege

Director

Read Laura Brege's Bio

Badreddin Edris, Ph.D.

Director and Co-Founder

Read Badreddin Edris, Ph.D.'s Bio

Jonathan C. Fox, M.D., Ph.D., FACC

Director

Read Jonathan C. Fox, M.D., Ph.D., FACC's Bio

Kevin Koch, Ph.D.

Director

Read Kevin Koch, Ph.D.'s Bio

Arlene Morris

Director

Read Arlene Morris's Bio

Jon Root, M.D.

Director

Read Jon Root, M.D.'s Bio

Alan Russell, Ph.D.

Director and Co-Founder

Read Alan Russell, Ph.D.'s Bio

Footer

Edgewise Therapeutics
  • Disease Areas
  • Science & Pipeline
  • Patients & Families
  • Company
  • Investors & News

Deep knowledge of integrated 
muscle physiology

Learn more about how our science is driving a new understanding of muscle and its potential to transform human health.

Explore our Science

2025 © Copyright. Edgewise Therapeutics. All Rights Reserved.

  • Privacy Policy
  • Terms of Use
Facebook X, formally Twitter LinkedIn Instagram YouTube
logo
  • Disease Areas
    • Muscular Dystrophy
    • Hypertrophic Cardiomyopathy
  • Science & Pipeline
    • Pipeline
    • Sevasemten
    • EDG-7500
    • Clinical Trials
    • Posters & Presentations
  • Patients & Families
    • Support for Becker
    • Support for Duchenne
    • Support for HCM
    • Patient Stories
  • Company
    • Leadership Team
    • Careers
    • Contact Us
  • Investors & Media
    • Corporate Profile
    • News
    • Events & Presentations
    • Analyst Coverage
    • Stock Info
      • Stock Quote
      • Stock Chart
      • Historical Stock Quote
      • Investment Calculator
    • Financials
      • Quarterly Results
      • SEC Filings
    • Goverance
      • Governance Documents
      • Committee Composition
    • Resources
      • Investor FAQs
      • Investor Email Alerts
      • Investor Contacts